QM · rank #5 · 2026-10-27
DD
NYSE · $18.44B (USD)
The exact numbers the algorithm saw.
| Momentum 12-1 Return from 12 months ago to 1 month ago. | +318.64% |
|---|---|
| ROE TTM Return on equity, trailing 12 months. | +1.8% |
| Profit margin Net profit margin, trailing 12 months. | +0.8% |
| Market cap (USD) Size filter: > $500M required. | $18.44B |
| Anchor (recent) Close on 2026-09-25 | $131.71 |
| Anchor (far) Close on 2025-09-26 | $31.46 |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
DuPont de Nemours is a specialty chemicals supplier in healthcare, water technologies and diversified industrial applications, with recent growth supported by bioprocessing and purification product launches.
Rationale
The stock’s 12-1 momentum is backed by improving fundamentals at DD—Q2 sales, EBITDA and EPS all grew, cash flow was strong, and management lifted full-year guidance.
Material risks
- 1Open-ended PFAS litigation and remediation obligations, even after the North Carolina settlement, can still absorb capital and pressure valuation.
- 2The newer chromatography and purification offerings have no disclosed backlog or customer commitments, so upside may prove more cyclical than structural.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 1 of 3 voted to proceed.